Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics
- 1 April 2013
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 114 (7) , 858-868
Abstract
Many patients with cancer experience physical disability following diagnosis, although little is known about the mechanisms underlying these functional deficits. To characterize skeletal muscle adaptations to cancer in humans, we evaluated skeletal muscle structure and contractile function at the molecular, cellular, whole-muscle, and whole-body level in 11 patients with cancer (5 cachectic, 6 noncachectic) and 6 controls without disease. Patients with cancer showed a 25% reduction in knee extensor isometric torque after adjustment for muscle mass (P < 0.05), which was strongly related to diminished power output during a walking endurance test (r = 0.889; P < 0.01). At the cellular level, single fiber isometric tension was reduced in myosin heavy chain (MHC) IIA fibers (P = 0.05) in patients with cancer, which was explained by a reduction (P < 0.05) in the number of strongly bound cross-bridges. In MHC I fibers, myosin-actin cross-bridge kinetics were reduced in patients, as evidenced by an increase in myosin attachment time (P < 0.01); and reductions in another kinetic parameter, myosin rate of force production, predicted reduced knee extensor isometric torque (r = 0.689; P < 0.05). Patients with cancer also exhibited reduced mitochondrial density (−50%; P < 0.001), which was related to increased myosin attachment time in MHC I fibers (r = −0.754; P < 0.01). Finally, no group differences in myofilament protein content or ultrastructure were noted that explained the observed functional alterations. Collectively, our results suggest reductions in myofilament protein function as a potential molecular mechanism contributing to muscle weakness and physical disability in human cancer.Keywords
This publication has 64 references indexed in Scilit:
- Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancerLung Cancer, 2012
- Skeletal Muscle PowerExercise and Sport Sciences Reviews, 2012
- Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative StressAntioxidants & Redox Signaling, 2011
- Myosin heavy chain is not selectively decreased in murine cancer cachexiaInternational Journal of Cancer, 2011
- Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humansThe Journal of Physiology, 2010
- Impact of Cancer on Health-Related Quality of Life of Older AmericansJNCI: Journal of the National Cancer Institute, 2009
- Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial FissionJournal of Biological Chemistry, 2009
- Reduced knee extensor function in heart failure is not explained by inactivityInternational Journal of Cardiology, 2009
- Skeletal muscle properties and fatigue resistance in relation to smoking historyEuropean Journal of Applied Physiology, 2008
- Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patientsBritish Journal of Cancer, 2007